SCHEDULE: Saba Capital Discloses 6.95% Stake in Sharps Technology

Saba Capital Management, L.P. and Boaz R. Weinstein have reported a 6.95% beneficial ownership stake in Sharps Technology, Inc. common stock and warrants.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein filed a Schedule 13G indicating a collective beneficial ownership of 3,050,450 shares.
• The reported stake represents 6.95% of the outstanding common stock of Sharps Technology, Inc.
• The ownership calculation includes 42,322,168 shares outstanding as of May 8, 2026, plus 1,538,462 shares issuable upon the exercise of warrants held by the reporting persons.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine regulatory disclosure of institutional ownership that does not imply a change in company strategy.

Positives

• Institutional investor interest from a significant firm like Saba Capital suggests potential confidence in the company's long-term value.

Negatives

• The filing indicates the acquisition is for investment purposes only and not intended to influence or change control of the issuer.

Risks

• Market volatility associated with small-cap equity and warrant holdings.
• Potential dilution risks if additional shares are issued by the company.

Future Outlook

The reporting persons state that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that institutional filings like this are standard in the small-cap medical technology sector, often signaling that sophisticated investors are building positions in companies with specific intellectual property or market niches.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investors exceeding a 5% ownership threshold.
• The use of a Schedule 13G (rather than 13D) confirms the passive nature of the investment, consistent with typical hedge fund portfolio management.

Stakeholder Impact

• Shareholders may view the entry of a major institutional investor as a validation of the company's market position.

Next Steps

• Monitoring of future 13G/A filings for changes in position size.

Key Dates

Keywords

Sharps Technology, Saba Capital, Schedule 13G, Institutional Ownership, Beneficial Ownership, STSS